A novel stellate mesoporous silica-based pH-responsive nanophotosensitizer can be localized and specifically activated at tumor site for cancer diagnosis and targeted PDT.
A drug delivery system mediated by Schiff base interaction incorporated mesoporous organosilica nanoparticles exhibits tumor/pH-responsive degradability and enhanced anti-cancer efficacy.